Breast cancer is among the most common cancers in females around the world and for many years Tamoxifen has remained as one of the effective treatments that most doctors would prescribed. However, a new research study claims that Tamoxifen has long term preventive benefits and have managed to reduce the breast cancer rates by almost a third. The new analysis expanded upon the International Breast Cancer Intervention Study weighs the long term risks and benefits of Tamoxifen. The reports that have come in have proved that Tamoxifen has been effective and that doctors can now go ahead confidently and prescribe it to the patients.
One of the biggest challenges of treating cancer is that cancer cells can evade attack from body’s immune system and eventually spread and create more complications. However, scientists have come up with immunotherapy that orders the immune system to go into the attack mode to fight cancer and build a long lasting immune resistance for cancer cells. As per the new research at the Harvard School of Engineering and Applied Sciences and the Wyss Institute of Biologically Inspired Engineering a new breed of non-surgical injection has been made that immediately assembles in vivo into a 3D structure and can fight and prevent cancer cells and even HIV cells.
We all know about obesity and cancer as two of the most life threatening diseases, but in a new study it has been found that obesity is associated with more than half a million new cancer cases worldwide each year. The new report highlights that nearly two thirds of obesity related cancers are found in North America and Europe. The report shows analysis of data from more than 184 countries globally. It indicates that excess weight is directly associated with 345,000 (5.4 %) of new cancer cases in women and 136,000 (1.9%) new cancer cases in men in 2012.
Researchers are always looking out for better ways to treat major health problems like cancer. According to the new study by scientists at the National Cancer Institute, part of the National Institutes of Health patients that had Hodgkin lymphoma and who had certain radiation and chemotherapy regimens were at the risk of developing stomach cancer. Scientists that have worked on the study have mentioned more about their research in the Journal of Clinical Oncology for the readers. The research claims that Hodgkin lymphoma is a cancer that develops from the immune system and it remains one of the common cancers found in young adults in the United States. The treatment involves various kinds of chemotherapy and radiotherapy regimens that can actually help the patients to get better.
Cancer still remains one of the worst nightmares for health patients around the world that suffer from it. While lung cancer remains the leading cause of death by cancer in the United States for males, prostate cancer takes the second spot with more than 2 million deaths annually across the United States. The numbers are even higher across the globe and many male patients are now going through various medical procedures that can allow them to diagnose and treat prostate cancer in early stages so that it can be cured immediately. Prostate Specific Antigen remains one of the most popular ways to detect such cancer early when cure is possible but there are many unknown facts that are now coming to light.
Brain tumor is very difficult to cure
Glioblastoma or brain cancer is extremely lethal in kind. Curing it is one of immense difficulty. Malignancy of this kind does not respond too well to radiation therapy. That’s because malignant cells spread and cause havoc at a breakneck speed. In fact, it is very difficult to distinguish between the different stages of glioblastoma. The first stage of malignancy, which begins with cell invasion closely, follows the stage marking the development of tumor. The stages are closely interlinked. Studies have indicated that cancer cells of the mentioned kind are potentially capacitated into affecting the remote regions of brain. It calls for specialized treatment- the one different from those prescribed for other varieties of malignancy.